Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report) today. The company’s ...
Bristol Myers Squibb (BMS) has shared positive five-year results from a long-term extension (LTE) study of its oral TYK2 ...
Bristol Myers Squibb announces positive data from POETYK PSO LTE trial of Sotyktu to treat moderate-to-severe plaque psoriasis: Princeton, New Jersey Tuesday, February 18, 2025, 1 ...
CanSino Biologics Inc. (CanSinoBIO or the Company), a leading Chinese vaccine innovator, has been invited to the 2025 World Government Summit in Dubai from February 11-13. Dr Yu Xuefeng, Chairman and ...
Five-year data from the POETYK PSO long-term extension trial confirm the sustained efficacy and safety of Sotyktu ...
US-based pharmaceutical company Bristol Myers Squibb (BMS) has reported results from the POETYK PSO long-term extension (LTE) ...
Squibb announced new five-year results from the POETYK PSO long-term extension trial of Sotyktu treatment in adult patients ...
The Internet is Leaking: Public Dashboard Tracks Billions of Exposed Assets and Secrets in Real Time
RedHunt Labs has introduced a real-time Internet Attack Surface Dashboard, tracking millions of exposed assets, leaked credentials, and misconfigured cloud services daily. With 18M+ new subdomains, 3, ...
No new safety signals observed at Year 5 in the POETYK PSO long-term extension trial, consistent with the established Sotyktu ...
European leaders trying to make sense of a tough new line from Washington on issues including democracy and Ukraine’s future ...
Israel’s defense minister says “all hell will break loose” if Hamas does not release three hostages as planned this weekend.
Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback